Carrier consent is where a streamlined close most often stalls, because buyers treat it as a closing-week formality when it's a months-long workstream. The appointments are the asset — without carrier consent, the buyer can't write the carrier's business — and the consent clauses vary wildly across a single agency's contracts. Running the approval as a tracked process, starting at the LOI, is what keeps a carrier "no" from becoming a closing surprise that reshapes the economics.
§ 01 · Four severity tiersWhat the clause demands.
| Tier | What it requires |
|---|---|
| Notice-only | Notify by a deadline — no carrier approval right (mildest) |
| Consent (reasonableness) | Carrier may not unreasonably withhold consent |
| Consent (sole discretion) | Carrier may decline without a stated reason |
| Automatic termination | Contract terminates by its terms; agency re-applies under current terms |
The clauses sort into four severity tiers. Notice-only is the mildest — the agency must notify the carrier by a specified deadline, with no carrier approval right. Consent with a reasonableness standard is the middle ground — the carrier may not unreasonably withhold consent. Consent at sole discretion lets the carrier decline without a stated reason. And automatic termination is the most severe — the contract terminates by its own terms, and the agency re-applies under the carrier's current (rather than legacy) terms, which can strip negotiated enhancements. The crucial reality is the mixed portfolio: a single agency typically holds contracts spanning all four tiers, so a buyer's diligence team cannot assume uniform treatment and has to map each carrier contract individually. The carrier-diligence view of these same clauses is in carrier change-of-control.
§ 02 · Assignment vs. change-of-controlAnd the approval clock.
The deal structure determines which restriction triggers: an asset purchase triggers assignment restrictions as contracts move to the buyer's entity, while a stock purchase preserves the entity but triggers change-of-control clauses — so a buyer assuming a stock deal avoids the issue is often wrong. The approval clock runs 30 days for large nationals, 60–90 days for mid-size carriers, and longer in the E&S market, which is why filing the request two weeks before closing is almost always a mistake.
Two timing realities govern the workstream. First, the structure question: an asset purchase triggers assignment restrictions when the contracts move to the buyer's entity, while a stock purchase preserves the entity but triggers the change-of-control clauses — so the buyer's legal team maps each carrier contract against the proposed structure, and the common assumption that a stock deal sidesteps consent is frequently wrong. Second, the clock: the carrier approval cycle runs about 30 days for large national carriers, 60–90 days for mid-size carriers, and longer still in the excess-and-surplus market, where multiple underwriting-review rounds are common. Those timelines are why the consent request can't wait for the closing run-up — a 90-day cycle on a key carrier against a target close date means the request has to go out early in diligence, which is the whole reason carrier consent is a workstream rather than a task.
§ 03 · The approval sequence and the "no"Process and contingency.
Each material carrier moves through a five-step formal approval sequence: an initial notification submitted within the contract's notice period; a carrier information request (the buyer's financials, org, appointment history, regulatory actions, and book-continuation plan); an internal review (marketing, underwriting, sometimes senior leadership); a decision (approval, approval-with-conditions — by far the most common when any condition arises, or denial); and post-approval documentation (new appointment paperwork, a revised or assumed contract, and a possible transition commission or contingency schedule). When a carrier says "no," a buyer has four responses: accept the commercial consequences (a small-share carrier's book moves to replacements or stays an orphan appointment, with the valuation adjusting), restructure the deal (rare, when the declining carrier is central enough to reshape economics), seek reconsideration (territory-level conversations and senior escalation), or walk — because a carrier representing 10%+ of commission with a contingency tier refusing to transfer can make the deal uneconomic. The rep-and-escrow protections that back this are in the reps-and-warranties process.
§ 04 · Contingency-bonus treatmentAnd the APA mechanisms.
A carrier's consent isn't the whole question — the contingency bonus may or may not survive the transfer, and the treatment follows three patterns. It travels with the book (the most seller-favorable, increasingly rare — new ownership inherits the tier, loss-ratio history, and growth basis), it resets (new ownership starts fresh with a new tier and measurement period, sometimes after a probationary period — costing a meaningful year of contingency income), or it terminates (the most carrier-favorable — eligibility ends until a new agreement). Because contingency is 6%–10% of direct-bill commission in strong years, the pattern is meaningful enough to move valuation — and contingency agreements are frequently separate documents from the main appointment, so they must be inventoried and read separately. Two purchase-agreement mechanisms manage the whole carrier risk: a carrier-retention escrow (a holdback released as each significant carrier formally approves the transition) and a change-of-control MAC provision tied specifically to carrier non-approval (a threshold-defined adjustment or termination right). Run the five-step sequence early, map each clause and contingency agreement, and back it with the escrow and MAC — that's how the appointments get secured at close rather than scrambled for. The operational consent mechanics from the synergy lens are in carrier appointment transfer.
◆
Terminology on this shelf
- Four severity tiers
- Notice-only, consent (reasonableness), consent (sole discretion), automatic termination.
- Assignment vs. change-of-control
- Asset deals trigger assignment restrictions; stock deals trigger change-of-control.
- Approval clock
- 30 days (nationals), 60–90 (mid-size), longer (E&S) — file early, not two weeks out.
- Five-step sequence
- Notification, information request, internal review, decision, post-approval documentation.
- Four responses to a "no"
- Accept consequences, restructure, seek reconsideration, or walk (10%+ carrier can make it uneconomic).
- Contingency treatment
- Travels, resets, or terminates — meaningful at 6%–10% of direct-bill commission.